Differential effects of opioid peptides on myocardial ischemic tolerance

Journal of Surgical Research

Volumn 119, Issue 1, 2004, Pages 46-50

  Romano, Matthew A ^a   McNish, Robert ^a   Seymour, Elisabeth M ^a   Traynor, John R ^a   Bolling, Steven F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

ischemia; myoprotection; opioid; preconditioning

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; FENTANYL; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE PEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG TOLERANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PERFUSION; HYPOTHERMIA; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOTONIC AGENTS; ENKEPHALIN, LEUCINE-2-ALANINE; FENTANYL; HEART; MICROSCOPY, ELECTRON; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; OPIOID PEPTIDES; OXYGEN CONSUMPTION; RABBITS; RECOVERY OF FUNCTION;

EID: 2342630605     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.01.006     Document Type: Article

References (29)

1. Benedict P.E., et al. Opiate drugs and delta-receptor-mediated myocardial protection. Circulation. 100:(19 Suppl):1999;II357
2. Oeltgen P.R., et al. Further studies on opioids and hibernation Delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci. 43:1988;1565
3. Chien S.F., et al. Functional studies of the heart during a 24-hour preservation using a new autoperfusion preparation. J. Heart Lung Transplant. 10:1991;401
4. Bolling S.F., et al. Hibernation triggers and myocardial protection. Circulation. 98:(19 Suppl):1998;II220. discussion II223
5. Bolling S.F., et al. Use of "natural" hibernation induction triggers for myocardial protection. Ann. Thorac. Surg. 64:1997;623
6. Horton N.D., et al. Isolation and partial characterization of an opioid-like 88 kDa hibernation-related protein. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 119:1998;787
7. Bolling S.F., et al. The use of hibernation induction triggers for cardiac transplant preservation. Transplantation. 63:1997;326
8. Meerson F.Z., Ustinova E.E., Orlova E.H. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin. Cardiol. 10:1987;783
9. Bofetiado D.M., Mayfield K.P., D'Alecy L.G. Alkaloid delta agonist BW373U86 increases hypoxic tolerance. Anesth. Analg. 82:1996;1237
10. Mayfield K.P., D'Alecy L.G. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res. 582:1992;226
11. Mayfield K.P., D'Alecy L.G. Delta-1 opioid receptor dependence of acute hypoxic adaptation. J. Pharmacol. Exp. Ther. 268:1994;74
12. Mayfield K.P., D'Alecy L.G. Delta-1 opioid agonist acutely increases hypoxic tolerance. J. Pharmacol. Exp. Ther. 268:1994;683
13. Chien S., et al. Extension of tissue survival time in multiorgan block preparation with a delta opioid DADLE ([D-Ala2, D-Leu5]-enkephalin). J. Thorac. Cardiovasc. Surg. 107:1994;964
14. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia A delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124
15. Sigg D.C., et al. Opioid preconditioning Myocardial function and energy metabolism. Ann. Thorac. Surg. 72:2001;1576
16. Sigg D.C., et al. Role of delta-opioid receptor agonists on infarct size reduction in swine. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H1953
17. Wang G.Y., et al. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H384
18. Wu S., Li H.Y., Wong T.M. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ. Res. 84:1999;1388
19. Kato R., Ross S., Foex P. Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br. J. Anaesth. 84:2000;204
20. Wang T.L., et al. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc. Res. 40:1998;557
21. Wang T.L., et al. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction. Am. J. Cardiol. 80:1997;1532
22. Schultz J.J., Hsu A.K., Gross G.J. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J. Mol. Cell Cardiol. 29:1997;2187
23. Ela C., et al. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors. J. Mol. Cell Cardiol. 29:1997;711
24. Traynor J.R., Elliott J. delta-Opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol. Sci. 14:1993;84
25. Schultz J.E., et al. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268:(5 Pt. 2):1995;H2157
26. Schultz J.E., Hsu A.K., Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ. Res. 78:1996;1100
27. Schultz J.E., Hsu A.K., Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation. 97:1998;1282
28. Kevelaitis E., et al. Opening of potassium channels The common cardioprotective link between preconditioning and natural hibernation? Circulation. 99:1999;3079
29. Chen Y., Yu L. Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel. J. Biol. Chem. 269:1994;7839